---
{"dg-publish":true,"permalink":"/USMLE/Neurology/Serotonin syndrome/"}
---

# Epidemiology


---
# Etiology
## Serotonergic drugs
- [[USMLE/Psychiatry/Antidepressants\|Antidepressants]] (e.g., MAOIs, [[USMLE/Psychiatry/Antidepressants\|SSRIs]], SNRIs, tricyclic [[USMLE/Psychiatry/Antidepressants\|antidepressants]], vortioxetine, vilazodone, trazodone)
- Anxiolytics (e.g., [[USMLE/Psychiatry/Antidepressants\|buspirone]])
- [[USMLE/Neurology/Anticonvulsant drugs\|Anticonvulsants]] (e.g., [[USMLE/Neurology/Anticonvulsant drugs\|valproate]])
- <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Pharmacology/Opioids\|Opioids]] (e.g., tramadol, meperidine)</span>
- NMDA receptor antagonists (e.g., dextromethorphan)
- [[USMLE/GI/Antiemetics\|5-HT3 receptor antagonists]] (e.g., ondansetron)
- [[USMLE/Neurology/Neurotransmitters\|Serotonin]] receptor agonists (e.g., triptans, ritonavir)
- <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Pharmacology/Antibiotics\|Antibiotics]] (e.g., linezolid)</span>
- Herbal supplements (e.g., St. John's wort, ginseng, <span style="background:rgba(240, 200, 0, 0.2)">tryptophan</span>)
	- <span style="background:rgba(240, 200, 0, 0.2)">Tryptophan is precursor of [[USMLE/Neurology/Neurotransmitters\|serotonin]]</span>![Pasted image 20231215101227.png](/img/user/appendix/Pasted%20image%2020231215101227.png)
- Recreational stimulants (e.g., [[USMLE/Neurology/MDMA\|MDMA]], cocaine)

>[!tip] 
>Serotonin syndrome rarely occurs with a single serotonergic drug used at therapeutic doses.  More commonly, it is due to the <span style="background:rgba(240, 200, 0, 0.2)">combined effects of several serotonergic medications, overdose, and/or a drug-drug interaction.</span> E.g. a depressed patient also takes linezolid.

---
# Pathophysiology
![Pasted image 20240808103618.png](/img/user/appendix/Pasted%20image%2020240808103618.png)

---
# Clinical features
![Pasted image 20240315213536.png](/img/user/appendix/Pasted%20image%2020240315213536.png)
- Onset: acute, typically within 24 hours of administration of the causative drug
- <span style="background:rgba(240, 200, 0, 0.2)">Classic triad</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Autonomic dysfunction</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Diaphoresis</span>
		- Tachycardia
		- [[USMLE/Cardiology/Hypertension\|Hypertension]]
		- Mydriasis
	- <span style="background:rgba(240, 200, 0, 0.2)">Neuromuscular excitability: can lead to hyperthermia</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Contrast to [[USMLE/Neurology/Parkinson disease\|Parkinson disease]]</span>
		- Hyperreflexia
		- Myoclonus
		- [[USMLE/MSK/Spasticity (Clonus) vs Rigidity\|Clonus]]
		- Horizontal ocular [[USMLE/MSK/Spasticity (Clonus) vs Rigidity\|clonus]]
		- Hypertonicity
		- [[USMLE/MSK/Spasticity (Clonus) vs Rigidity\|Rigidity]] (especially in the lower extremities)
	- <span style="background:rgba(240, 200, 0, 0.2)">Altered mental status</span>
		- [[USMLE/Psychiatry/Delirium\|Delirium]]
		- Psychomotor agitation

![Pasted image 20240115220336.png](/img/user/appendix/Pasted%20image%2020240115220336.png)

---
# Diagnostics


---
# Treatment
- <span style="background:rgba(240, 200, 0, 0.2)">Agitation and excessive muscle activity: Treat with [[USMLE/Psychiatry/Sedative-hypnotic drugs\|benzodiazepines]].</span>
- Hyperthermia: Initiate cooling measures, e.g., by reducing ambient temperature, applying cooling blankets or ice packs, administering cold IV fluids. 
- Autonomic instability
	- Give antihypertensive treatment.
	- Treat [[USMLE/Psychiatry/Antidepressants\|MAOI]]-induced hypotension or shock.
- Moderate to severe and/or refractory cases
	- <span style="background:rgba(240, 200, 0, 0.2)">Consider treatment with 5-HT2A receptor antagonists: cyproheptadine</span>

---
